Billionaire Cliff Asness’ Top 10 Healthcare Stock Picks
Cliff Asness is a billionaire investor and the co-founder and chief investment officer of AQR Capital Management, a quantitative hedge fund.
Bristol Myers Squibb Co (BMY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Skylands Capital Charles Paquelet | 138,725 | $7,993,335 | -2% | 0.98% |
| 2. | Lee Munder Capital Group Lee Munder | 5,673 | $326,878 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $47.58 | 4,250 | $202,215.00 | 83,513 | 2025-04-25 | Filing | |
| $55.05 | 2,000 | $110,096.00 | 104,626 | 2025-02-20 | Filing | |
| $54.84 | 1,823 | $99,999.97 | 63,932 | 2025-02-14 | Filing | |
| $54.68 | 1,830 | $100,055.25 | 62,109 | 2024-11-01 | Filing | |
| $49.78 | 2,000 | $99,560.00 | 82,672 | 2023-12-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $62.05 | 4,481 | $278,046.05 | 159,248 | 2026-04-01 | Filing | |
| $61.60 | 25,519 | $1,571,970.40 | 163,729 | 2026-04-01 | Filing | |
| $47.33 | 56,000 | $2,650,480.00 | 167,379 | 2025-09-02 | Filing | |
| $44.23 | 378 | $16,718.94 | 5,066 | 2025-08-02 | Filing | |
| $38.01 | 97 | $3,701.83 | 0 | 2025-05-09 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,244,630 | $417,435,581 | 0.51% | |
| 2. | 3,053,480 | $175,941,518 | 1.57% | |
| 3. | 3,043,205 | $175,349,471 | 0.15% | |
| 4. | 2,396,422 | $138,081,835 | 0.2% | |
| 5. | 2,304,823 | $132,803,901 | 0.67% |
News See All
Is Bristol-Myers Squibb Company (BMY) Stock at Risk From Proposed Medicare Drug Price Negotiation Updates?
TheFly reported on June 15 that RBC Capital analyst Trung Huynh noted that the proposed changes to the Medicare Drug Price Negotiation Program could introduce potential risks for companies, including ...
12 Best Low-Priced Pharma Stocks to Buy Right Now
Investors looking for large returns without making a sizable initial commitment are still drawn to low-priced companies.
12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On
On May 27, Reuters reported that Biohub, a philanthropic venture formed by Meta CEO Mark Zuckerberg and Dr. Priscilla Chan, developed a global model of protein biology to speed up drug discovery.
12 Most Undervalued Stocks to Invest In
Undervalued stocks are getting more attention as investors look for opportunities outside the crowded growth trade.
BMO Capital Maintains Market Perform Rating on Bristol-Myers (BMY) After Earnings Beat
Bristol-Myers Squibb Company (NYSE:BMY) ranks among the best retirement stocks to buy now.
8 Best Retirement Stocks to Buy Now
A great many people struggle to determine how much money they will need to live comfortably in retirement, especially as retirement expenses rise annually.
12 Best Dividend Stocks to Invest In According to Hedge Funds
Investors tend to favor dividend stocks in times of market volatility and economic uncertainty, as we have seen in recent months.
10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen
On April 30, Bloomberg reported that Steve Cohen resigned as president of Point72 Asset Management, and Harry Schwefel was appointed co-CIO.
Bristol-Myers Squibb Company (NYSE:BMY) Q1 2026 Earnings Call Transcript
Operator: Welcome to the Bristol-Myers Squibb First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.